Seventeen years ago saw the first blasting in the historic heartland of Switzerland of the longest train tunnel in the world. Wednesday 1 June 2016 will see the festive opening of the Gotthard Base Tunnel – adding a further pioneering attraction to the world's densest public transport network. The tunnel will bring Switzerland's neighbouring countries, regions and cities north and south of the Alps closer together. Travel by train will be quicker, easier and more convenient.
Wednesday 1 June 2016 sees the festive opening in Switzerland of the longest and deepest train tunnel in the world. The tunnel extends for 57 kilometres to a depth of up to 2300 metres below the Gotthard massif. This flagship project for efficient and sustainable transportation on the north-south axis will permit high-speed travel through the Alps in only 17 minutes. The new flat-track route will not only cut travel time through the Gotthard, but also facilitate transit travel for longer and heavier trains. After 17 years of challenging building work, constructor AlpTransit Gotthard Ltd will hand over the completed tunnel to the Swiss Federal Railways on time and on budget. Switzerland's internationally acclaimed public transport system – already the densest in the world – has perfected another pioneering first.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7828351-swiss-alps-longest-deepest-train-tunnel/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
https://youtu.be/P8-Hc53sAjI The U.S. is about to get on board with a critical form of credit card payment and retailers need to be prepared. Retailers are getting ready to make the switch from primarily accepting traditional magnetic strip cards to EMV. EMV – Europay, Mastercard and Visa – is a credit card with a small chip that more securely validates transactions than magnetic strip cards. Much of the world uses EMV and Europe has used EMV for years.
Although the NHS is ranked as one of the institutions that makes people ‘most proud to be British’1, a new poll commissioned by Astellas Pharma Europe Ltd, highlights that 91% of people feel that the health service is in need of change2. In particular, shorter waiting times (36% of respondents) and improved access to medicines (30%) rank most highly as the areas in need of greatest reform.
With only 1 in 4 of respondents agreeing that the Government currently spends enough on health, the survey reveals that those polled would be willing to accept an average charge of £10 for a missed GP appointment in order to improve service levels. The people polled also said they would be willing to pay an average of £170 per year in additional income tax for healthcare funding – which could result in approximately £5 billion in additional tax revenue for the Treasury3. In addition to these charges, 39% of those polled would be willing to accept an additional charge if it meant quicker access to healthcare services and 44% of those polled would be willing to accept additional charges if it meant access to newer and potentially more effective medicines.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7753151-astellas-survey-public-support-nhs-concern/
FedEx, acteur majeur du transport express international, se prépare pour faire face à des volumes record, avec 317 millions d'envois expédiés à travers le monde entre le Black Friday (27 novembre) et la veille de Noël (24 décembre), soit une hausse de 12,4 % par rapport à 2014. FedEx prévoit d'embaucher plus de 55 000 collaborateurs temporaires dans le monde pour faire face au prochain pic saisonnier, notamment des agents de manutention, des conducteurs et d'autres membres du personnel qui soutiendront notre activité.
Avec 16 000 collaborateurs, une flotte de plus de 3 000 véhicules et 39 avions, et un réseau de 327 agences en Europe, FedEx bénéficie d'une présence renforcée sur l’ancien continent. L’entreprise dispose donc de tous les atouts pour prendre en charge les importants volumes attendus sur l'ensemble de la région, à une époque où l'essor de l'e-commerce et les changements dans les habitudes d'achat des consommateurs participent à l'accroissement des envois. Selon E-commerce Europe,1 15 % des habitants de l'Union européenne ont acheté en ligne des biens et/ou des services auprès de vendeurs situés en dehors de leur pays de résidence, soit une hausse de 25 % en glissement annuel.
To view the multimedia release go to:
http://www.multivu.com/players/fr/7719651-fedex-saison-fetes-envois-achemines/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The European Head and Neck Society (EHNS) and the Make Sense Campaign, today announced the launch of the Third Annual Head and Neck Cancer Awareness week (21–25 September). Through the pan-European Awareness Week, the EHNS and Make Sense Campaign promote education on head and neck cancer risk factors, disease prevention and disease signs and symptoms for both patients and healthcare professionals.
“Each year 350,000 people are diagnosed with head and neck cancer across Europe, and over half will not be alive after five years. However, if diagnosed and treated earlier, patients can have an 80 – 90% survival rate.” said Professor René Leemans, President of the EHNS and Professor and Chief of Otolaryngology – Head and Neck Surgery at VU University Medical Centre. “Through the Make Sense Campaign we are educating people about the early signs of the disease and encouraging them to seek professional help in a timely manner. Additionally, we are advocating for the best possible standards of patient care so that their outcomes can be optimised once they have been diagnosed with the disease.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7628151-support-head-neck-cancer-patients/
Klarna, Europe’s leading payment solutions providers, today announced the official launch of commercial operations in the U.S. with Overstock.com as its first major retail partner. According to Overstock.com, this partnership will bring a simplified buying experience on mobile devices, enabling Overstock.com shoppers the ease of buying from their smartphone or tablet with just one tap.
“We’re incredibly excited to launch Klarna in the U.S. To do so together with a partner of such a massive scale as Overstock gives us a huge boost into the market”, said Brian Billingsley, CEO of Klarna North America. “U.S. consumers are looking for a simpler and safer way to buy and retailers are looking for better ways to engage their consumers and increase their checkout conversion. The early success we’ve had with Overstock show the massive opportunity to turn more browsers into buyers.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7600151-klarna-launches-overstock-u-s/
